...
首页> 外文期刊>Journal of Internal Medicine >Radiocontrast-induced natriuresis associated with increased urinary urodilatin excretion.
【24h】

Radiocontrast-induced natriuresis associated with increased urinary urodilatin excretion.

机译:放射性造影剂引起的尿钠排泄与尿中urodilatin排泄增加有关。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: Intravascular radiocontrast agents induce a pronounced diuresis. The aim of the present study was to investigate the (patho-)physiological mechanisms of the radiocontrast-induced diuresis. DESIGN: The fractional excretion of sodium, the urinary excretion of the renal natriuretic peptide urodilatin and the plasma concentration of atrial natriuretic peptide were measured in 42 unselected patients immediately before and after intravascular radiocontrast administration during coronary angiography. SETTING: Cardiac catheterization laboratory of a university hospital. RESULTS: After angiography both the plasma concentration of atrial natriuretic peptide (median post-pre difference: 3.9 pmol L(-1), quartiles -1.2; 7.0) and the urinary excretion of urodilatin (median post-pre difference: 67.0 nmol urodilatin/mol creatinine, quartiles 39.7; 152.1) were increased. The urinary urodilatin excretion was correlated with an increase in the fractional excretion of sodium (median post-pre difference: 1.7%, quartiles 0.6; 3.1). There was no correlation between the serum concentration of atrial natriuretic peptide and urinary sodium excretion. For the radiocontrast-induced increase in both urodilatin and sodium excretion there was no indication for differences between patients without (31) and with (11) intravenous saline infusion. CONCLUSION: The radiocontrast-induced diuresis is a natriuresis which is associated with an increased urinary excretion of urodilatin. The association between natriuresis and urinary urodilatin excretion irrespective of baseline volume status corroborates the hypothesis that urodilatin contributes to the sodium excretion after radiocontrast administration in a paracrine manner. This finding has pathophysiological and potentially therapeutic implications in radiocontrast-induced nephropathy.
机译:目的:血管内造影剂可引起明显的利尿作用。本研究的目的是研究放射性造影剂利尿的(病理)生理机制。设计:在42例未选择的患者中,在冠脉造影术中进行血管内造影剂注射前后,分别测量了钠的分数排泄,肾利钠肽尿泌素和尿钠的血浆浓度以及心钠素的血浆浓度。地点:大学医院的心导管检查实验室。结果:血管造影后,心房利钠肽的血浆浓度(中位数后差异:3.9 pmol L(-1),四分位数-1.2; 7.0)和尿苷的尿排泄(中位数差异后:67.0 nmol urodilatin /摩尔肌酐,四分位数39.7; 152.1)增加。尿中urodilatin排泄与钠的分数排泄增加相关(事后中位数差异:1.7%,四分位数0.6; 3.1)。心钠素的血清浓度与尿钠排泄之间没有相关性。对于放射性造影剂引起的urodilatin和钠排泄的增加,没有迹象表明没有(31)和(11)静脉注射生理盐水的患者之间存在差异。结论:放射性造影剂利尿是一种利尿,与尿苷的尿排泄增加有关。尿钠排尿与尿中尿嘧啶核苷排泄之间的相关性,与基线量状态无关,这证实了尿嘧啶核苷以旁分泌方式给予放射性对比剂后有助于钠排泄的假设。该发现在放射性造影剂引起的肾病中具有病理生理学和潜在的治疗意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号